About DR. PAUL EDWARD GOSS MBBCH. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Pritzker. Paul E. Goss, Michael Jarman, Leslie J. Griggs. Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis, Kathrin Strasser-Weippl, Ritesh Ramchandani, Lei Fan, Junjie Li, Marc Hurlbert, Dianne M. Finkelstein, Zhi Ming Shao, Paul E. Goss, Competing risks of death in younger and older postmenopausal breast cancer patients, Judy Anne W. Chapman, Kathleen I. Pritchard, Paul E. Goss, James N. Ingle, Hyman B. Muss, Susan Dent, Theodore A. Vandenberg, B. Findlay, Karen A. Gelmon, Carolyn F. Wilson, Lois E. Shepherd, Michael Pollak, Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy, Yanin Chavarri-Guerra, Michaela J. Higgins, Jackie Szymonifka, Tessa Cigler, P Liedke, Ann H. Partridge, Jennifer A. Ligibel, Steven E. Come, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, Elizabeth Maunsell, Rowan T. Chlebowski, James N. Ingle, Harriet Richardson, Paul E. Goss, Access to care issues adversely affect breast cancer patients in Mexico: oncologists perspective, Yanin Chavarri-Guerra, Jessica St. Louis, Pedro E.R. Extended adjuvant endocrine therapy in breast cancer: current status and future directions. NCIC CTG MA.17: Intent to treat analysis (ITT) of randomized patients after a median follow-up of 54 months. He is from . Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective. Dr. Goss' office is located at (617) 726-6500. Loss of heterozygosity of tumor suppressor genes in testis cancer. With a Table of Contents and an Index. 2. Mirza Jacqueline Alcalde-Castro, Enrique Soto-Perez-de-Celis, Alfredo Covarrubias-Gmez, Sofa Snchez-Romn, Paulina Quiroz-Friedman, Africa Navarro-Lara, Wendy Alicia Ramos-Lopez, Mara Luisa Moreno-Garca, Sergio Contreras-Garduo, Viridiana Perez-Montessoro, Paul E. Goss, Yanin Chavarri-Guerra, Sarah Barry Lincoln, Enrique Soto-Perez-de-Celis, Yanin Chavarri-Guerra, Alfredo Covarrubias-Gmez, Mariana Navarro, Paul E. Goss. Find out how to adopt this simple step into your daily oral health regimen. He also leads large practice changing clinical . 4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. Dr. Goss New Body Products SAG (Silica) . Celine M. Vachon, JN Ingle, Vera J. Suman, Christopher G. Scott, H. Gottardt, Janet E. Olson, Paul E. Goss. L C. Los Angeles, CA. Mutations of the p53 gene do not occur in testis cancer. Cost-effectiveness of extended adjuvant letrozole after five years of tamoxifen in postmenopausal early breast cancer. Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3-A randomized, placebo-controlled clinical trial. Directions. He grew up in a small company town, Alcoa, Tennessee. Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer, Nadine Tchen, Helen G. Juffs, Fiona P. Downie, Qi-long Yi, Hanxian Hu, Irene Chemerynsky, Mark Clemons, Michael Crump, Paul E. Goss, David Warr, Mary E. Tweedale, Ian F. Tannock. Rossana Ruiz, Carmen Herrero, Kathrin Strasser-Weippl, Diego Touya, Jessica St. Louis, Alexandra Bukowski, Paul E. Goss. Moyo VM, Higgins MJ, Aravelo-Araujo R, Iannotti N, Charu V, Dhindsa N, Goss PE. van de Velde, Eva Carrasco, Miguel Angel Segui, Jens Uwe Blohmer, Serban Costa, Bernd Gerber, Christian Jackisch, Gunter von Minckwitz, Mario Giuliano, Michele De Laurentiis, Christina Bamia, Georgia-Angeliki Koliou, Dimitris Mavroudis, Roger A'Hern, Paul Ellis, Lucy Kilburn, James P Morden, John Yarnold, Mohammad Sadoon, Augustinus H Tulusan, Stewart J. Anderson, Gordon Bass, J. Costantino, James J. Dignam, Bernard Fisher, Charles E. Geyer, Eleftherios P. Mamounas, Soon Paik, Carol Redmond, D. Lawrence Wickerham, M. Venturini, Claudia Bighin, Simona Pastorino, Paolo Pronzato, Mario Roberto Sertoli, Theodorus Foukakis, Kathy S. Albain, Rodrigo Arriagada, Elizabeth Bergsten Nordstrm, Francesco Boccardo, Etienne Brain, Lisa A. Carey, Alan S. Coates, Robert E. Coleman, C Correa, Jack Cuzick, Nancy E. Davidson, Mitch Dowsett, Marianne Ewertz, John F. Forbes, Richard D. Gelber, Aron Goldhirsch, Pamela J. Goodwin, Daniel F. Hayes, Christopher Hill, James N. Ingle, Reshma Jagsi, Wolfgang Janni, Hirofumi Mukai, Yasuo Ohashi, Lori J. Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomas. A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. Let us know if this information is out of date or incorrect. Yanin Chavarri-Guerra, Enrique Soto-Perez-de-Celis, Wendy Alicia Ramos-Lopez, Sandra L. San Miguel de Majors, Jesus SanchezGonzalez, Samuel AhumadaTamayo, Lorena Viramontes-Aguilar, Oscar SanchezGutierrez, Bernardo Davila-Davila, Patricia Rojo-Castillo, Viridiana Perez-Montessoro, Alexandra Bukowski, Paul E. Goss, Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials, Richard Gray, Rosie Bradley, Jeremy P Braybrooke, Z Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn W. Taylor, William E. Barlow, Judith M Bliss, Paolo Bruzzi, David Cameron, George Fountzilas, Sibylle Loibl, John R. Mackey, Miguel Martn, Lucia Del Mastro, Volker Mbus, Valentina Nekljudova, Sabino De Placido, Sandra M. Swain, Michael Untch, Kathleen I. Pritchard, Jonas Bergh, Larry Norton, Clare Boddington, Julie Ann Burrett, Mike Clarke, C Davies, Fran Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert Kerrin Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep S. Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, Jean Marie Nogaret, Catherine Philippson, Martine Piccart, Sabine C. Linn, Petronella Peer, Vivianne C. G. Tjan-Heijnen, Sonja Vliek, Dennis J. Slamon, John D. Bartlett, Vivien H.C. Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond B. Weiss, Yi Shan, Yong Fu Shao, Xiang Wang, Binghe Xu, Dong-Bing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fatima Cardoso, Tanja Cufer, J.P. Julien, Philip Poortmans, Emiel J. Th. Shopping Cart - 0 Items; 201 547-3520 . Rutgers, Cornelis J.H. Angela Brodie, L.Y. Publication date 2021-08-28 Usage Attribution-NonCommercial 4.0 International Topics dr. gaz, memorial compton Language English. Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms. Effects of adjuvant exemestane versus anastrozole on bone mineral density: Two-year results of the NCIC CTG MA.27 bone companion study. NCIC CTG MA.17: Tolerability of letrozole among ethnic minority women. Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism. New, Annette M. O'Connor, Mark Olsen, Barbara A. Parker, Howard L. Parnes, Jeffrey Perlman, Joann Pinkerton, Trevor J. Powles, Jerilynn C. Prior, Kathleen I. Pritchard, Joseph Ragaz, Elda Railey, Nina Rumen, Mary Ropka, Ronald K. Ross, Carol Sawka, Rena V. Sellin, Craig Slingluff, Sandra M. Swain, Phyllis Tysenhouse, Nelson B. Watts, Elizabeth Whamond, Michael Wills. Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies. Anglica Nogueira-Rodrigues, Alexandra Bukowski, Eduardo Paulino, Jessica St. Louis, Adriana Barrichello, Cinthya Sternberg, Markus A. C. Gifoni, Silvana Luciani, Paul E. Goss. The Cushing syndrome induced by medroxyprogesterone acetate. Dr. New Body Products Or Dr. Paul Goss founder of New body Products There is a really DANGEROUS ingredient in the ckls product called CHAPARRAL. Aromatase inhibitors and their potential clinical significance. Specific homeodomain-DNA interactions are required for HOX11-mediated transformation. (310) 537-4793. its about a 2hrs drive from the Tucson airport.. Doc Mitchell, the Root Doctor . The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats. James N. Ingle, Dongsheng Tu, Joseph L. Pater, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Paul E. Goss. Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trial. Frances A. Shepherd, Ronald L. Burkes, Karen Paul, Paul E. Goss. its about a 2hrs drive from the Tucson airport.. It gives you a detailed description of each herb and what each herb is good for based off your health issues. Denosumab and the current status of bone-modifying drugs in breast cancer. Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Please verify your coverage with the provider's office directly when scheduling an appointment. MB BCH University of Witwatersrand 1978: PhD University of London 1986 . 464 W Compton Blvd Compton CA 90220. Mark Clemons, Sarah Danson, T Hamilton, Paul E. Goss, Aromatase inhibitors in the treatment and prevention of breast cancer. Goss and his colleagues in the United . Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model. Avon and the Avon Breast Cancer Crusade mark 25 year legacy of raising breast cancer awareness. Paul Goss Dr. Paul Goss, founder and president of NEW BODY PRODUCTS, was the 8th child of 10 born to Sam and Annie Goss in Canton, Georgia. Order Online. Dr. Goss New Body Products CAP (Calcium Phosphate of Lime) $ 26.00. Dr. Goss used Iridology, Herbal Remedies and Vegetarian diets for healing, and did so since 1965. Claim this business. He is affiliated with medical facilities such as Lehigh Valley Hospital - Cedar Crest and Penn . Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation. Website. Karina J. Matissek, Maristela L. Onozato, Sheng Sun, Zongli Zheng, Andrew Schultz, Jesse Lee, Kristofer Patel, Piiha Lotta Jerevall, Srinivas Vinod Saladi, Allison MacLeay, Mehrad Tavallai, Tanja Badovinac-Crnjevic, Carlos H. Barrios, Nuran Bese, Arlene Chan, Yanin Chavarri-Guerra, Marcio Debiasi, Elif Demirdogen, Unal Egeli, Sahsuvar Gokgoz, Henry L. Gomez, Pedro Er Liedke, Ismet Tasdelen, Sahsine Tolunay, Gustavo Werutsky, Jessica St. Louis, Nora Horick, Dianne M. Finkelstein, Long P. Le, Aditya Bardia, Paul E. Goss, Dennis C. Sgroi, A. John Iafrate, Leif W. Ellisen, Patient Navigation to Improve Access to Breast Cancer Care in Brazil, Alexandra Bukowski, Sandra Gioia, Yanin Chavarri-Guerra, Enrique Soto-Perez-de-Celis, Jessica St. Louis, Eduardo Paulino, Anglica Nogueira-Rodrigues, Paul E. Goss. . Physician Investigator (Cl) Mass General Research Institute Professor of Medicine Harvard Medical School Research Staff Hematology-Oncology, Massachusetts General Hospital Education. Is there ever a role for salvage operations in limited small-cell lung cancer? Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. More. Proceedings of the first international conference on recent advances and future directions in endocrine therapy for breast cancer: Summary consensus statement, Aman U. Buzdar, Steven E. Come, Angela Brodie, Paul E. Goss, Matthew J. Ellis, Stephen R. D. Johnston, James N. Ingle, Adrian V. Lee, C. Kent Osborne, Victor G. Vogel, Carol S. Hart, Does treatment at the time of locoregional failure of breast cancer alter prognosis. Spends appropriate amount of time with patient and provides thorough examinations. Measuring swainsonine in serum of cancer patients: phase I clinical trial. Relatives, jobs, social network profiles - Radaris people search engine. High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer. Hide; Accessibility Tools. Learn the difference between Medicare and Medigap with our simple guide. Accepting new patients. Dr. Paul Goss, founder and president of New Body Products, was the eighth child of ten born to Sam and Annie Goss in Canton, Georgia. Add to wishlist. Thomas E. Delea, Jonathan Karnon, Robert E. Smith, Stephen R. D. Johnston, J. Brandman, Jennifer Sung, Paul E. Goss. Examination of POU homeobox gene expression in human breast cancer cells. Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report. He received his medical degree from University of the Witwatersrand and has been in practice for more than 20 years. Paul E. Goss, Lynn Schwertfeger, Martin E. Blackstein, Neill A. Iscoe, Robert J. Ginsberg, William J. Simpson, Donald P. Jones, Frances A. Shepherd, A Phase I Study of Swainsonine in Patients with Advanced Malignancies, Paul E. Goss, Jose Baptiste, Berny Fernandes, Michael Baker, James W. Dennis. Prez Carrin R, Alberola Candel, F. Calabresi, Michel Rt, R Santos, Delozier T, Paul E. Goss, L. Mauriac, Feuilhade F, Freue M, Branching N-Linked Oligosaccharides in Breast Cancer, Bozena Korczak, Paul E. Goss, B Fernandez, Michael Baker, James W. Dennis, Identification, cloning, and characterization of a novel human T-cell- specific tyrosine kinase located at the hematopoietin complex on chromosome 5q, Spencer B. Gibson, Bernadine Leung, Jeremy A. Squire, Mary Hill, Naomichi Arima, Paul E. Goss, David Hogg, Gordon B. Risks versus benefits in the clinical application of aromatase inhibitors. I didn't find this out until after I tried to reorder the product again and I had never received my products from the company. Lived In Akron OH, Holland OH, Toledo OH, Sacramento CA. Patterson, Ronald Feld, Paul E. Goss, F.G. Pearson, T.J.R. An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation. Dr. Paul Goss, MD Dr. Paul Goss, MD. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Liedke, Enrique Soto-Perez-de-Celis, Don S. Dizon, Eduardo Cazap, Gilberto Lopes, Diego Touya, Joo Soares Nunes, Jessica St. Louis, Caroline Vail, Alexandra Bukowski, Pier Ramos-Elias, Karla Unger-Saldaa, Denise Froes Brandao, Mayra Ferreyra, Silvana Luciani, Anglica Nogueira-Rodrigues, Aknar Calabrich, Marcela G. del Carmen, Jose Alejandro Rauh-Hain, Kathleen M. Schmeler, Raul Sala, Paul E. Goss. Anti-aromatase agents in the treatment and prevention of breast cancer. High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases, Rick Abraham, Tracy Nagy, Paul E. Goss, Michael Crump. Aman U. Buzdar, R. Charles Coombes, Paul E. Goss, Eric P. Winer, The Emerging Role of the Insulin-Like Growth Factor Pathway as a Therapeutic Target in Cancer. The symptoms of Parkinson's disease and essential tremors may be similar, but there are key differences, as well. James N. Ingle, Fang Xie, Matthew J. Ellis, Paul E. Goss, Lois E. Shepherd, Judith Anne W. Chapman, Bingshu E. Chen, Michiaki Kubo, Yoichi Furukawa, Yukihide Momozawa, Vered Stearns, Kathleen I. Pritchard, Poulami Barman, Erin E. Carlson, Matthew P. Goetz, Richard M. Weinshilboum, Krishna R. Kalari, Liewei Wang, Current and emerging therapies of HER2-positive metastatic breast cancer, Abraham Hernndez-Blanquisett, Diego Touya, Kathrin Strasser-Weippl, Rossana Ruiz, Jessica St. Louis, Paul E. Goss. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer. Amanda B. Marietta, GA. 93. . Michael Crump, Paul E. Goss, Miles Prince, Caroline Girouard. Jing Xu, Tanya Keenan, Beth Overmoyer, Nadine Tung, Rebecca Gelman, Karleen Habin, Judy Garber, Leif W. Ellisen, Eric P. Winer, Paul E. Goss, Beow Y. Yeap, Bruce A. Chabner, Steven J. Isakoff. Rated highly on their manner and listening skills. Stearns V, Chapman JW, Ma CX, Ellis MJ, Ingle JN, Pritchard KI, Budd GT, Rabaglio M, Sledge GW, Le Maitre A, Kundapur J, Shepherd LE, Goss PE. General Hematology + 1 more subspecialties. Paul E. Goss, S Qi, Robert G. Josse, Kenneth P.H. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Shepherd, F. A., Goss, P. E., Latreille, J., Stewart, D., Logan, D., Evans, W. K., Maroun, J., Warner, E. An Alert to Latin America: Current Human Papillomavirus Vaccination Trends Highlight Key Barriers to Successful Implementation. Alexandra Bukowski, Yanin Chavarri-Guerra, Paul E. Goss, Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years, Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Nicholas J. Robert, Hyman B. Muss, Julie R. Gralow, Karen A. Gelmon, Timothy J. Whelan, Kathrin Strasser-Weippl, Sheldon Rubin, Keren Sturtz, Antonio C. Wolff, Eric P. Winer, Clifford A. Hudis, Alison Stopeck, J. Thaddeus Beck, Judith S. Kaur, Kate Whelan, Dongsheng Tu, Wendy R. Parulekar, New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole Analyses from NCIC CTG MA.17, P Liedke, Dongsheng Tu, Lois E. Shepherd, Yanin Chavarri-Guerra, Kathleen I. Pritchard, Vered Stearns, Paul E. Goss, Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17, Rachel Anne Goodwin, Rahima Jamal, Christopher M. Booth, Paul E. Goss, Elizabeth Eisenhauer, Dongsheng Tu, Lois E. Shepherd, Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14, Judith-Anne W. Chapman, Dennis C. Sgroi, Paul E. Goss, Elizabeth Zarella, Shemeica Binns, Yi Zhang, Catherine A. Schnabel, Mark G. Erlander, Kathleen I. Pritchard, Lei Han, Tanja Badovinac-Crnjevic, Lois E. Shepherd, Michael Pollak, Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27, Judith Anne W. Chapman, Lois E. Shepherd, James N. Ingle, Hyman B. Muss, Kathleen I. Pritchard, Karen A. Gelmon, Timothy J. Whelan, C. Elliott, Paul E. Goss, Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy, Kathrin Strasser-Weippl, Nora Horick, Ian E. Smith, Joyce O'Shaughnessy, Bent Ejlertsen, Frances M. Boyle, Aman U. Buzdar, Pierre Fumoleau, William J. Gradishar, Miguel Martin, Beverly Moy, Martine Piccart-Gebhart, Kathleen I. Pritchard, Deborah Lindquist, E. Rappold, Dianne M. Finkelstein, Paul E. Goss, Cervical cancer control in Latin America: A call to action, Brittany L. Bychkovsky, Mayra Ferreyra, Kathrin Strasser-Weippl, Christina I. Herold, Gilberto Lopes, Don S. Dizon, Kathleen M. Schmeler, Marcela G. del Carmen, Thomas C. Randall, Anglica Nogueira-Rodrigues, Aknar Calabrich, Jessica St. Louis, Caroline Vail, Paul E. Goss. Your Price: $12.95. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Useful 2. The provider is registered as an . Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. He received the basis for an international education not in the poorly funded segregated school, but from two African Elders. Kathleen I. Pritchard, Paul E. Goss, Lois E. Shepherd. Liedke, Judy-Anne W. Chapman, Lois E. Shepherd, Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer, Kathrin Strasser-Weippl, Tanja Badovinac-Crnjevic, Lei Fan, Paul E. Goss, Yanin Chavarri-Guerra, Richard Sullivan, Paul E. Goss, Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker, Dennis C. Sgroi, Erin Carney, Elizabeth Zarrella, Lauren Steffel, Shemeica Binns, Dianne M. Finkelstein, Jackie Szymonifka, Atul K. Bhan, Lois E. Shepherd, Yi Zhang, Catherine A. Schnabel, Mark G. Erlander, James N. Ingle, Peggy L. Porter, Hyman B. Muss, Katherine I. Pritchard, Dongsheng Tu, David L. Rimm, Paul E. Goss. Tongue scraping is an easy routine to remove food and bacteria from the surface of the tongue. Competing risks in low-risk breast cancer. Drugs such as tamoxifen (Nolvadex), raloxifene (Evista), and exemestane (Aromasin) can reduce the odds of developing breast cancer for many women at risk. Pierce, Vinod Raina, Peter M. Ravdin, Daniel Rea, Meredith M. Regan, John F.R. Moy, B., Kirkpatrick, P., Kar, S., Goss, P. Breast cancer in women < or = 35 years: review of 1002 cases from a single institution. James N. Ingle, Krishna R. Kalari, Poulami Barman, Lois E. Shepherd, Matthew J. Ellis, Paul E. Goss, Aman U. Buzdar, Mark E. Robson, Junmei Cairns, Erin E. Carlson, Abraham Eyman Casey, Tanya L. Hoskin, Barbara Goodnature, Tufia C. Haddad, Matthew P. Goetz, Richard M. Weinshilboum, Liewei Wang, Eduardo Paulino, Andreia Cristina de Melo, Agnaldo L. Silva-Filho, Luiza de Freitas Maciel, Luiz Claudio Santos Thuler, Paul E. Goss, Anglica Nogueira-Rodrigues, Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action, Junmei Cairns, James N. Ingle, Tanda M. Dudenkov, Krishna R. Kalari, Erin E. Carlson, Jie Na, Aman U. Buzdar, Mark E. Robson, Matthew J. Ellis, Paul E. Goss, Lois E. Shepherd, Barbara Goodnature, Matthew P. Goetz, Richard M. Weinshilboum, Hu Li, Mehrab Ghanat Bari, Liewei Wang. Foster, Ann F. Chambers. He was raised in a company town called Alcoa, Tennessee. Printer Friendly View Address: 527 W Compton Blvd Compton, CA, 90220-3010 United States . Sgroi D, Hameed O, Hattab E, Chang B, Moulis S, Steffel L, Salunga R, Ma X, Erlander M, Goss P, Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17, James N. Ingle, Dongsheng Tu, Joseph L. Pater, Hyman B. Muss, Silvana Martino, Nicholas J. Robert, Martine Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Paul E. Goss, A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer, Xiao-Jun Ma, Ranelle C. Salunga, Sonika Dahiya, Wilson Wang, Erin Carney, Virginie Durbecq, Adrian L. Harris, Paul E. Goss, Christos Sotiriou, Mark G. Erlander, Dennis C. Sgroi, Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis, Scott D. Solomon, Janet Wittes, Peter V. Finn, Robert A. Fowler, Jaye L. Viner, Monica M. Bertagnolli, Nadir Arber, Bernard Levin, Curtis L. Meinert, Barbara K. Martin, Joseph L. Pater, Paul E. Goss, Peter Lance, Stefanie Obara, Emily Y. Chew, Jonghyeon Kim, Gretchen Arndt, Ernest T. Hawk, Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen, Paul E. Goss, James N. Ingle, Joseph L. Pater, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Dongsheng Tu, Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17, Hyman B. Muss, Dongsheng Tu, James N. Ingle, Silvana Martino, Nicholas J. Robert, Joseph L. Pater, Timothy J. Whelan, Michael Palmer, Martine Piccart, Lois E. Shepherd, Kathleen I. Pritchard, Zhi He, Paul E. Goss.